Drug shortages were a recurring problem in the US healthcare system long before the COVID-19 pandemic. While many factors affect supply chain complications, the overriding one is that the country's pharmaceutical system operates on a "just-in-time" system rather than one that predicts and prevents issues. Check out the dashboards below for the most recent shortages, or take a look at the complete PDF list, updated every week.

Download Critical Acute & COVID-19 Drug Lists

 


156 Critical Acute Drugs List

(updated 1.31.23)

  • 47%: 73 of 156 critical acute drugs in shortage by ASHP
  • 23%: 36 of 156 critical acute drugs in shortage by FDA

In 2018, the Resilient Drug Supply Project (RDSP) and a panel of experts from government, academia, and the private sector created a list of 156 critical acute drugs which, by definition, are drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death. Absence of a critical acute drug, or lack of availability of an effective substitute, may cause serious health outcomes or limited ability to provide humane care."

Recent shortages:

  • Insulin detemir injection (Jan 2023, ASHP)
  • Phenytoin sodium injection (Jan 2023, ASHP)
  • Tirzepatide (Dec 2022, ASHP)
  • Methylphenidate hydrochloride (Dec 2022, ASHP)
  • Argatroban (Dec 2022, FDA)
  • Azithromycin injection (Dec 2022, ASHP)
  • Morphine injection (Sep 2022, ASHP)
  • Oxytocin injection (Sep 2022, ASHPFDA)

RECENT RESOLUTIONS:

  • Prochlorperazine maleate (Dec 2022, ASHP)
  • Cefazolin (Dec 2022, FDA)
  • Continuous renal replacement therapy (Sep 2022, FDA)
  • Cefepime injection (Sep 2022, ASHP)
  • Morphine PCA vials (Aug 2022, ASHP)
  • Atracurium injection (Aug 2022, ASHP)
  • Mycophenolate mofetil (Aug 2022, ASHP)
  • Cisatracurium besylate (Aug 2022, ASHP)

40 Critical COVID-19 Drugs

(updated 1.31.23)

  • 58%: 23 of 40 critical COVID-19 drugs in shortage by ASHP
  • 38%: 15 of 40 critical COVID-19 drugs in shortage by FDA

RECENT SHORTAGES:

  • Gentamicin (Jul 2022, FDA)

ASHP Drug Shortages

  • 73 drugs are currently in shortage by ASHP standards (updated 1.31.23)

The American Society for Health-System Pharmacists (ASHP) defines a drug shortage as "a supply issue that affects how the pharmacy prepares or dispenses a drug product or influences patient care when prescribers must use an alternative agent." This data is largely reliant on health system pharmacist reports.


FDA Drug Shortages

  • 36 drugs are currently in shortage by FDA standards (updated 1.31.23)

The US Food and Drug Administration (FDA) defines a drug shortage as "a period of time when the demand or projected demand for the drug within the U.S. exceeds its supply." This data is largely reliant on manufacturer reports.

 

Our underwriters